PMS2 and cancer: All seven cancers showing concomitant MLH1 somatic hypermethylation and germline MLH1 variants displayed immunohistochemical loss of expression of both MLH1 and PMS2, presented with a high level of MSI, and belonged to five families (Figure 2, Figure 3 and Figure 4a).